Identification of differentially expressed genes in tobacco chewing-mediated oral cancer by differential display-polymerase chain reaction

European Journal of Clinical Investigation

Volumn 37, Issue 8, 2007, Pages 658-664

  Nagpal, J K ^a,c   Das, B R ^b  

^a INSTITUTE OF LIFE SCIENCES   (India)

^b SRL Ranbaxy Ltd   (India)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

CDK6; DD PCR; DEK; Oral cancer; Sorcin; Tobacco chewing

Indexed keywords

CALCIUM BINDING PROTEIN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE 6; SORCIN;

ARTICLE; AUTOIMMUNE DISEASE; CARCINOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MOLECULAR CLONING; MOUTH CANCER; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

BLOTTING, NORTHERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DEVELOPING COUNTRIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOUTH NEOPLASMS; POLYMERASE CHAIN REACTION; TOBACCO, SMOKELESS;

EID: 34447324979     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2007.01841.x     Document Type: Article

References (33)

1. Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczynski SP. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997 9 : 595 604.
2. Francia G, Mitchell SD, Moss SE, Hanby AM, Marshall JF, Hart IR. Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression. Cancer Res 1996 56 : 3855 8.
3. Sharma R, Samantaray S, Shukla NK, Ralhan R. Transcriptional gene expression profile of human esophageal squamous cell carcinoma. Genomics 2003 81 : 481 8.
4. Fournier MV, Guimareas FC, Paschoal MEM, Ranco LV, Carvalho MGC, Pardee AB. Identification of a gene encoding a human oxysterol-binding protein-homologue: a potential general molecular marker for blood dissemination of solid tumors. Cancer Res 1999 59 : 3748 53.
5. Morita M, Yoshiuchi N, Arakawa H, Nishimura S. CMAP: a novel cystatin-like gene involved in liver metastasis. Cancer Res 1999 59 : 151 8.
6. Liang P, Averboukh L, Keyomarsi K, Sager R, Pardee AB. Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res 1992 52 : 6966 8.
7. Yonekura H, Migita H, Sakurai S, Wang H, Harada S, Abedin MJ et al. Antisense display - a method for functional gene screening: evaluation in a cell-free system and isolation of angiogenesis-related genes. Nucleic Acid Res 1999 27 : 2591 600.
8. Jung MH, Kim SC, Jeon GA, Kim SH, Kim Y, Choi KS et al. Identification of differentially expressed genes in normal and tumor human gastric tissue. Genomics 2000 69 : 281 6.
9. Kim DG. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma. Methods Mol Biol 2006 317 : 141 55.
10. Huang LR, Coughtrie MW, Hsu HC. Down-regulation of dehydroepiandrosterone sulfotransferase gene in human hepatocellular carcinoma. Mol Cell Endocrinol 2005 231 : 87 94.
11. Iwasaki K, Bajenova E, Somogyi-Ganss E, Miller M, Nguyen V, Nourkeyhani H et al. Amelotin: a novel secreted, ameloblast-specific protein. J Dent Res 2005 84 : 1127 32.
12. Ryu HH, Jung S, Sun HS, Jung TY, Jin SG, Jin YH et al. Screening for motility-associated genes in malignant astrocytoma cell lines. J Neurooncol 2007 82 : 125 31.
13. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 1984 81 : 1991 5.
14. Von Lindern M, Fornerod M, van Baal S, Jaegle M, de Wit T, Buijs A et al. The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA. Mol Cell Biol 1992 12 : 1687 97.
15. Dong X, Wang J, Kabir FN, Shaw M, Reed AM, Stein L et al. Autoantibodies to DEK oncoprotein in human inflammatory disease. Arthritis Rheum 2000 43 : 85 93.
16. Wichmann I, Garcia-Lozano JR, Respaldiza N, Gonzalez-Escribano MF, Nunez-Rolden A. Autoantibodies to transcriptional regulation proteins DEK and ALY in a patient with systemic lupus erythematosus. Hum Immunol 1999 60 : 57 62.
17. Fu GK, Grosveld G, Markovitz DM. DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer. Proc Natl Acad Sci USA 1997 94 : 1811 5.
18. Kappes F, Burger K, Baack M, Fackelmayer FO, Gruss C. Subcellular localization of the human proto-oncogene protein DEK. J Biol Chem 2001 276 : 26317 23.
19. Chen Q, Lin J, Jinno S, Okayama H. Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation. Oncogene 2003 22 : 992 1001.
20. Obaya AJ, Kotenko I, Cole MD, Sedivy JM. The proto-oncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 to facilitate the activation of Cdk4/6 and early G1 phase progression. J Biol Chem 2002 277 : 31263 9.
21. Piboonniyom SO, Timmermann S, Hinds P, Munger K. Aberrations in the MTS1 tumor suppressor locus in oral squamous cell carcinoma lines preferentially affect the INK4A gene and result in increased cdk6 activity. Oral Oncol 2002 38 : 179 86.
22. Brito-Babapulle V, Gruszka-Westwood AM, Platt G, Andersen CL, Elnenaei MO, Matutes E et al. Translocation t(2;7)(p12;q21-22) with dysregulation of the CDK-6 gene mapping to 7q21-22 in a non-Hodgkin's lymphoma with leukemia. Haematologica 2002 87 : 357 62.
23. Lin J, Jinno S, Okayama H. Cdk6-Cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence. Oncogene 2001 20 : 2000 9.
24. Morris M, Hepburn P, Wynford-Thomas D. Sequential extension of proliferative lifespan in human fibroblasts induced by over-expression of CDK4 or 6 and loss of p53 function. Oncogene 2002 21 : 4277 88.
25. Pickel VM, Clarke CL, Meyers MB. Ultrastructural localization of sorcin, a 22 kDa calcium binding protein, in the rat caudate-putamen nucleus: association with ryanodine receptors and intracellular calcium release. J Comp Neurol 1997 386 : 625 34.
26. Hamada H, Okochi E, Oh-hara T, Tsuruo T. Purification of the Mr 22,000 calcium-binding protein (sorcin) associated with multidrug resistance and its detection with monoclonal antibodies. Cancer Res 1988 48 : 3173 8.
27. Roberts D, Meyers MB, Biedler JL, Wiggins LG. Association of sorcin with drug resistance in L1210 cells. Cancer Chemother Pharmacol 1989 23 : 19 25.
28. Parekh HK, Deng HB, Choudhary K, Hosur SR, Simpkins H. Overexpression of sorcin, a calcium-binding protein, induces a low level of paclitaxel resistance in human ovarian and breast cancer cells. Biochem Pharmacol 2002 63 : 1149 58.
29. Demidova NS, Ilyinskaya GV, Shiryaeva OA, Chernova OB, Goncharova SA, Kopnin BP. Decreased sensitivity of multidrug-resistant tumor cells to cisplatin is correlated with sorcin gene co-amplification. Neoplasma 1995 42 : 195 201.
30. Tan Y, Li G, Zhao C, Wang J, Zhao H, Xue Y et al. Expression of sorcin predicts poor outcome in acute myeloid leukemia. Leuk Res 2003 27 : 125 31.
31. Leethanakul C, Knezevic V, Patel V, Amornphimoltham P, Gillespie J, Shillitoe EJ et al. Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray analysis. Oral Oncol 2003 39 : 248 58.
32. Hwang D, Alevizos I, Schmitt WA, Misra J, Ohyama H, Todd R et al. Genomic dissection for characterization of cancerous oral epithelium tissues using transcription profiling. Oral Oncol 2003 39 : 259 68.
33. Alevizos I, Mahadevappa M, Zhang X, Ohayama H, Kohno Y, Posner M et al. Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 2001 20 : 6196 204.